Fibromyalgia: understanding the symptoms and finding support.
Pain may be what brings you to the appointment. Exhaustion, broken sleep, and difficulty thinking can shape the rest of the day.
Fibromyalgia is a long-term condition that causes widespread pain and tenderness, often with fatigue, unrefreshing sleep, and difficulty concentrating. Its causes are not fully understood, though altered pain processing is involved. Diagnosis requires clinical assessment. Care can combine education, adapted activity, psychological therapies such as ACT or CBT, sleep support, and medication selected with a clinician.
You might manage one part of the day and have little left for the next. Remembering a conversation can be difficult after a poor night, and explaining all of this in a short appointment can be difficult too. A useful account of fibromyalgia has to leave room for that experience.
This article draws on Fibromyalgia in Exam Preparation: Complete Overview, a 2015 lecture from Pain Specialists Australia, alongside later research and clinical guidance. We also consider what these lessons should mean for Cindra, the companion we are building.
What does fibromyalgia involve?
The National Institute of Arthritis and Musculoskeletal and Skin Diseases describes widespread pain, fatigue, and sleep difficulties as the main symptoms. Some people also experience stiffness, tenderness, sensitivity to light or noise, digestive problems, and difficulty with memory or concentration, often called fibro fog. Symptoms and their impact vary between people.
Research points to changes in how the nervous system processes pain. Increased sensitivity can help explain why touch or pressure hurts more than expected. It does not tell us everything about why fibromyalgia develops, or establish the cause of every symptom a person has.
The “volume control” analogy can make this easier to understand, provided we remember it is an analogy. A clinician cannot use it to conclude that a new symptom is harmless. Brain imaging findings from research groups are also different from a test that can diagnose an individual.
Fibromyalgia is not itself an inflammatory or autoimmune disease, but it can occur alongside conditions such as rheumatoid arthritis or lupus. The American College of Rheumatology recognizes both its physical symptoms and its effects on sleep and mood. Anxiety or depression may need care in their own right; their presence does not make pain imaginary.
How is fibromyalgia diagnosed?
There is no routine blood test or scan that confirms fibromyalgia. According to NIAMS guidance on diagnosis, clinicians consider the symptom pattern, medical history, and physical examination. Tests may help investigate other explanations or conditions that coexist with it. Normal results alone do not establish the diagnosis.
The video discusses older tender-point criteria and the then-new preliminary criteria. The 2016 revisions by Wolfe and colleagues later clarified generalized pain, symptom severity, and symptoms lasting at least three months. They also clarified that another diagnosis does not automatically rule out fibromyalgia, and fibromyalgia does not rule out another important illness. Their self-report criteria are not a substitute for individual clinical diagnosis.
For a patient, the practical question is what the assessment explains and what still needs attention. If symptoms change, tell your care team. A diagnosis should help organize care without making every later complaint disappear into the same label.
What can help with fibromyalgia?
There is no established cure, and no single treatment suits everyone. The aim is to find a combination that helps with symptoms and everyday life without creating an unmanageable burden. NHS treatment guidance describes exercise, talking therapies, and medication, with choices adapted to the person's preferences and needs.
- Movement that fits the person. Activity can help, but the starting point and adjustments should reflect health, capacity, and symptom response. A physiotherapist can help tailor a plan.
- Support with sleep and fatigue. Discuss persistent sleep problems, treatment side effects, and how much daily activity costs you. Rest and practical adaptations belong in the conversation.
- Psychological support. ACT and CBT offer skills for living with pain and distress. Choosing this support does not mean agreeing that the illness is psychological.
- A medication review. Ask what each medicine is intended to help, what unwanted effects to watch for, and when to review the result. Avoid changing prescribed treatment because of a video or an app suggestion.
The lecture's prescribing discussion is historical. For example, FDA labeling from August 2025 includes sublingual cyclobenzaprine, marketed as Tonmya, for adults with fibromyalgia. That is one reason older drug lists should not be treated as complete. Approval does not establish that a medicine is suitable for a particular person; interactions, contraindications, and tolerability still need a prescriber or pharmacist.
When activity causes a delayed crash
The video closes with chronic fatigue syndrome, but its criteria are dated. Current CDC guidance on ME/CFS includes post-exertional malaise: worsening after physical or mental effort, sometimes delayed. This deserves attention when someone reports fatigue alongside fibromyalgia. The conditions can overlap, and ordinary tiredness is not an adequate explanation for every crash.
If activity leaves you substantially worse later, describe the timing and duration to your clinician before increasing it. For people with ME/CFS, NICE advises against exercise programs with fixed incremental increases. That is a specific qualification to general exercise advice, not a reason to make everyone follow the same plan.
Where does ACT fit?
Acceptance and commitment therapy helps people respond more flexibly to difficult thoughts and feelings and make choices connected to what matters to them. In pain care, acceptance should leave room for treatment, rest, frustration, and asking for help. It should not become pressure to tolerate a worsening symptom or prove your commitment through activity.
There is relevant evidence for digital delivery. In the 2024 PROSPER-FM trial, 275 adults were assigned to a 12-week smartphone ACT program or an active comparison program with symptom tracking and educational materials. At 12 weeks, 71% of the ACT group reported improvement on a global rating of change, compared with 22% of the comparison group. This was a rating of overall change, not a claim that 71% were cured.
The trial was funded by Swing Therapeutics; 257 of the participants were women, and research staff were generally aware of assignment. Those details matter when interpreting the result and its applicability. It evaluated a particular structured intervention. It does not establish the effectiveness or safety of Cindra, an open-ended chatbot, or every app that uses ACT language.
For Cindra, the useful lesson is that the content and delivery need to be tested. A collection of reassuring messages or a symptom log cannot inherit the results of a clinical program. Our ACT safeguards commentary explores consent, symptom changes, and the freedom to stop.
What this means for Cindra
Fibromyalgia gives us a concrete design question: can the companion make a difficult day easier to organize without adding another obligation? Cindra's public concept includes conversations, learning, practices, and optional device support. The requirements below are our application of the evidence. They are not a claim that every capability is implemented, available, or clinically validated.
| What someone may need | How Cindra should respond |
|---|---|
| Too little energy for a long check-in | Offer a brief check-in, a way to save and return, and an easy skip. Missing a day should not trigger guilt or a lost-streak message. |
| Help remembering a difficult week | Offer an optional record of pain, energy, sleep, concentration, and what changed. Let the person correct the summary and choose what to share. |
| Symptoms that worsen after activity | Ask about delayed effects before suggesting more activity. Pause progression when worsening is reported and support a conversation with the treating clinician. |
| A goal that still feels like their own | Ask what matters today. Offer a small, optional ACT practice or practical next step, including rest or asking someone for help. |
| A new or different symptom | Keep a route to appropriate medical assessment. Do not automatically label it a flare, anxiety, or sensitization. |
| Control over tracking and sharing | Explain what is recorded, allow tracking to be reduced or stopped, and make any clinician sharing explicit. Never say a clinician was contacted unless that action actually succeeded. |
Device data needs the same restraint. A sleep estimate, heart-rate trend, or EEG wellness signal should prompt a question, not overrule the person's report. A reassuring reading cannot establish that pain is harmless. VR, audio, and guided practices should remain optional, with an easy exit and a quieter alternative when someone finds them uncomfortable.
Consider a hypothetical morning: a person reports poor sleep and says yesterday's activity left them worse today. A useful companion would help record that change, offer a shorter interaction, and make it easy to review the pattern with a clinician. Automatically increasing a step target because yesterday's target was completed would miss the information that matters.
What we would need to evaluate
A fibromyalgia pilot should measure more than app use. We would want to know whether people find daily tasks more manageable, whether sleep or fatigue changes, whether interactions feel burdensome, and whether advice contributes to symptom worsening or delayed care. Testing should include people with cognitive difficulty, sensory sensitivity, and overlapping conditions. Engagement alone cannot tell us whether support is helping.
What the video contributes, and what needs updating
Pain Specialists Australia published the roughly 23-minute lecture on September 27, 2015, for pain-specialist exam preparation. We reviewed the complete English auto-generated captions and selected video segments and slides. We did not perform a full audiovisual review.
- Around 0:48: the lecture introduces a condition with several symptoms, including widespread pain, fatigue, and sleep difficulties.
- Around 5:08: it discusses altered pain processing and several proposed biological mechanisms. These are an explanation of research, not an individual diagnostic test.
- Around 8:58: it recommends individualized, multidisciplinary care that considers pain, function, and other symptoms.
- Around 14:15: it explains then-new diagnostic criteria. The 2016 revisions discussed above supersede parts of that account.
- Around 21:18: it distinguishes fatigue and chronic fatigue syndrome. Current ME/CFS guidance adds essential context.
The strongest lesson for our platform is to listen beyond a pain score. The lecture is useful background, while current clinical guidance and product-specific evaluation must govern what we build.
Questions about fibromyalgia and support
Does a normal blood test mean the pain is not real?
No. Routine tests do not measure the whole experience of pain, and there is no routine blood test that confirms fibromyalgia. Results need to be interpreted alongside the history and examination. New symptoms can still need investigation.
Is fibromyalgia the same as ME/CFS?
No. They can share symptoms and can coexist. Post-exertional malaise is a core feature of ME/CFS. Tell a clinician if physical or mental activity causes substantial worsening afterward, especially when the effect is delayed.
Can ACT or an app cure fibromyalgia?
Neither should be presented as an established cure. ACT can be part of care, and particular digital programs have trial evidence. Those findings do not establish that Cindra produces the same results.
What could a useful fibromyalgia check-in include?
It could ask briefly about pain, energy, sleep, concentration, new symptoms, and what the person wants help with. The person should be able to skip questions, correct summaries, and decide whether tracking is useful.
Help shape the companion we are building.
Cindra is invite-only while Karuna Labs develops it with early members. Join the Cindra waitlist.
Educational commentary and proposed product requirements. Sources checked October 27, 2026. This article has not undergone clinical review and does not provide an individualized care plan. Cindra requires its own evaluation before clinical benefit can be claimed.